Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-30

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project, is to better understand the fluctuation of the level of uric acid in traumatized patients by making serial measurements during their hospitalization in the intensive care unit. In addition, the determinants (e.g. type of trauma, diseases, interventions) of the blood level of uric acid and its association with the development of organ failure will be sought.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Values of Plasma Soluble RAGE Levels and RAGE Polymorphisms for the Onset of Acute Respiratory Distress Syndrome in Critically Ill Patients

NCT02070536

Intensive Care Unit Population at High Risk for ARDS Development

COMPLETED

MR-proADM and CT-proET-1 During ICU Treatment

NCT03651635

Acute Phase Biomarkers Medical ICU Admitted Patients

COMPLETED

Indirect Calorimetry Versus Urea-creatinine Ratio to Evaluate Catabolism in Critically Ill Patients

NCT06244381

Critically Ill

COMPLETED

Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)

NCT03262155

Acute Respiratory Distress Syndrome Cardiogenic Shock

COMPLETED

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

NCT03355625

Extracorporeal Membrane Oxygenation Platelet Activation Platelet Aggregation +3 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trauma Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Direct admission to trauma center
* ≤ 3h after trauma
* ISS ≥ 16
* Received at least 1L of fluid at ER entrance

Exclusion Criteria

* Isolated head injury
* Isolated spine injury
* Chemotherapy within the last month
* Hematologic disease
* Chronic hemodialysis
* Uricase treatment within the last week
* Expected death within 48h

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No